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ABSTRACT
Aptamers are short single-stranded nucleic acids
with high affinity to target molecules and are applic-
able to therapeutics and diagnostics. Regardless of
an increasing number of reported aptamers, the
structural basis of the interaction of RNA aptamer
with proteins is poorly understood. Here, we
determined the 2.15A ˚ crystal structure of the Fc
fragment of human IgG1 (hFc1) complexed with an
anti-Fc RNA aptamer. The aptamer adopts a char-
acteristic structure fit to hFc1 that is stabilized by a
calcium ion, and the binding activity of the aptamer
can be controlled many times by calcium chelation
and addition. Importantly, the aptamer–hFc1 inter-
action involves mainly van der Waals contacts and
hydrogen bonds rather than electrostatic forces,
in contrast to other known aptamer–protein
complexes. Moreover, the aptamer–hFc1 interaction
involves human IgG-specific amino acids, rendering
the aptamer specific to human IgGs, and not
crossreactive to other species IgGs. Hence, the
aptamer is a potent alternative for protein A affinity
purification of Fc-fusion proteins and therapeutic
antibodies. These results demonstrate, from a
structural viewpoint, that conformational plasticity
and selectivity of an RNA aptamer is achieved by
multiple interactions other than electrostatic
forces, which is applicable to many protein targets
of low or no affinity to nucleic acids.
INTRODUCTION
Aptamers are folded single-stranded nucleic acids that can
target given molecules. The concept is based on the ability
of short (20–80 mer) sequences to fold, in the presence of a
target, into unique 3D structures, which allow the aptamer
to bind target molecules with high afﬁnity and speciﬁcity
(1–3). Therefore, aptamers can be thought of as
nucleic-acid analogs to antibodies. RNA aptamers are
selected from a combinatorial library of randomized se-
quences (4–8) by in vitro selection, known as SELEX (sys-
tematic evolution of ligands by exponential enrichment),
and the target molecules can be nucleic acids, proteins, or
small organic compounds. Aptamers have therefore many
potential uses in medicine and technology. The ﬁrst
aptamer-based therapeutic, Pegaptanib (Macugen),
which targets vascular endothelial growth factor, was
approved by the FDA in 2004 for the treatment of age
related macular degeneration (AMD) (9,10). Considering
the basic principles of aptamer selection, the high potential
of RNA to create a vast set of tertiary structures, which we
referred to as ‘RNA plasticity’ (11), is conceivable from
both the ‘RNA world’ hypothesis (12) and the concept of
‘molecular mimicry’ between RNA and protein (13).
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3D structures by X-ray crystallography or NMR spectros-
copy (14), only three high resolution structures of RNA
aptamers in complex with target proteins have been
reported: RNA aptamers in complex with NF-kB solved
at 2.45A ˚ (15), with bacteriophage MS2 capsid at 2.8A ˚
(16) and with thrombin at 1.9A ˚ resolutions (17). NF-kB
and bacteriophage MS2 capsid naturally bind to nucleic
acids. The crystal structures of RNA aptamers in complex
with NF-kB and bacteriophage MS2 capsid indicate that
the aptamers bind to the respective nucleic-acid-binding
sites and mimic naturally occurring electrostatic inter-
actions (16,18). Thrombin does not naturally bind to
nucleic acid, but bears an extensive positively charged
surface responsible for heparin binding. The crystal struc-
ture of an RNA aptamer in complex with thrombin
demonstrated that the RNA aptamer binds to the posi-
tively charged surface required for heparin binding (17).
Thus, the crystal structures determined to date have sug-
gested that RNA aptamers bind target proteins predom-
inantly through electrostatic forces.
Using SELEX, we have previously identiﬁed an RNA
aptamer containing 20-ﬂuoro pyrimidine nucleotides that
binds to the Fc portion of human IgG1 (hFc1) in the
presence of Ca
2+ and Mg
2+ (19). A unique characteristic
of the Fc fragments, including hFc1, is the absence of an
extensive positively charged molecular surface (20); it is
thus tempting to speculate that the RNA aptamer may
interact with the hFc1 via non-electrostatic forces. The
aptamer’s high speciﬁcity to human IgGs and its require-
ment of divalent cations for binding activity are additional
distinctive characteristics (19). This speciﬁcity provides us
with an alternative reagent for the mass puriﬁcation of
therapeutic antibodies (19), as described earlier. Protein
A afﬁnity chromatography is currently the most
common procedure used for puriﬁcation of humanized
or chimeric antibodies (21,22). This process requires an
acidic elution step, which may sometime cause unexpected
aggregation or denaturing of antibodies (22–24). Aptamer
bound IgGs are instead easily released from the aptamer
resin under neutral pH conditions using simple elution
buffers, such as an EDTA solution (19). This is a potential
advantage of aptamers for afﬁnity puriﬁcation. In this
study, to understand the structural basis of the
hyperspeciﬁcity and high afﬁnity of the anti-hFc1
aptamer as well as prompt release of bound IgG by
EDTA, we solved the crystal structure of the aptamer–
hFc1 complex at the 2.15-A ˚ resolution.
MATERIALS AND METHODS
Crystallization and data collection
Human IgG1 was purchased from Calbiochem (USA). To
produce Fc fragments, human IgG1 was digested with
papain (Wako Pure Chemical Industries Ltd, Japan) at
37 C for 1h in 100mM sodium phosphate (pH 7.2),
10mM L-cysteine and 2mM EDTA (molar ratio of
IgG1:papain is 17:1).The reaction was stopped by the
addition of protease inhibitor. The Fc fragment was
puriﬁed with Protein A column (GE Healthcare) (25).
The chemically synthesized RNA aptamer containing
20-ﬂuoropyrimidines (Figure 1a) was purchased from
GeneDesign Inc. (Japan) and puriﬁed as described previ-
ously (25). The previous NMR study indicated a 1:2 stoi-
chiometry of the Fc dimer:aptamer complex (19). Thus,
the aptamer was mixed with the Fc dimer in a molar ratio
of 1:2.2 (Fc dimer:aptamer) for crystallization. The ﬁnal
concentration of the Fc fragment was 7mgml
 1 and it was
stored at 193K (25). Crystals were grown at 293K by the
sitting-drop vapor-diffusion method by mixing the sample
with an equal volume of reservoir solution containing
0.1M Tris–HCl buffer (pH 8.0), 20% (w/v) PEG 1000
and 0.2M calcium acetate. The solution stirring technique
with a rotary shaker (26–28) produced the best diffracting
crystals.
The crystals were soaked brieﬂy in Paratone-N oil and
then frozen by rapidly submerging them in liquid nitrogen.
Diffraction of data sets was collected at the beam line
BL41XU in SPring-8. Crystals belonged to the space
group P21212 with the cell parameters a=83.59,
b=107.24, c=79.46A ˚ . Diffraction data were processed
with the program HKL2000 (29). Data statistics are
summarized in Table 1.
Structural determination and reﬁnement
The structure of hFc1 in complex with RNA aptamer was
determined by the molecular replacement method using
the program MOLREP (30) with the structure of the un-
complexed form of hFc1 (PDB entry: 1FC1) as a search
model. Reﬁnement procedure for IgG complexed with the
aptamer was carried out using the program CNS (31)
without non-crystallographic symmetry (NCS) restrains/
constraints. The structures were visualized and modiﬁed
using the programs O (Alwyn Jones, Uppsala University,
Sweden), and COOT (32).
The stereochemical qualities of the ﬁnal struc-
tures were assessed with programs PROCHECK (33).
Contact area values were calculated with the program
ICM Pro (Molsoft), in which all of the parameters
were used default. Figures were generated by PyMOL
(www.pymol.org), and structural comparisons were
carried out using the programs Chimera (34) and
LSQKAB (35).
SPR analysis of base substitution derivatives
30-end poly(dA) 16-tailed Apt8-2 (a functional derivative
of the aptamer in this study) and mutant RNAs were
prepared by chemical synthesis (Gene Design Inc.), and
the binding activity was measured by SPR using the
BIAcore2000 instrument (GE Healthcare). 50-biotinylated
poly(dT) 16 was ﬁrst bound to a streptavidin sensor chip
(BIAcore), and poly(dA) 16-tailed RNAs were
immobilized to the sensor chip ( 1000RUs) via hybrid-
ization to the poly(dT) 16 oligomer. Human IgG1 solution
(Calbiochem, 100–500nM) was injected, and complex for-
mation was monitored via the sensorgram coupled with
the BIAevaluation 3.0 software analysis (BIAcore). The
running buffer was a mixture of 145mM NaCl, 5.4mM
KCl, 1.8mM CaCl2, 0.8mM MgCl2 and 20mM Tris–HCl
(pH 7.6). A 6M urea solution was used for regeneration.
Nucleic Acids Research, 2010,Vol.38, No. 21 7823Repeated unfolding/refolding of anti-hFc1 aptamer resin
The refolding experiments were conducted with
BIAcore2000. The 50-biotinylated Apt8-2 was immobilized
on a streptavidin sensor chip (BIAcore, 1000RU). Human
IgG1, dissolved in binding buffer (Calbiochem, 400nM),
was injected. The composition of binding buffer was the
same as the running buffer shown above. The aptamer was
inactivated by injection of unfolding buffer (10mM
EDTA and 10mM Tris–HCl pH 7.6) and the released
IgG was washed out. Injections of the IgG solution and
the unfolding buffer were repeated 10 times.
RESULTS
Overall structure
To clarify the structural basis for the high speciﬁcity and
characteristic properties of the RNA aptamer, we have
determined the 2.15A ˚ crystal structure of the RNA
aptamer in complex with hFc1 (Figure 1). The ﬁnal
model, an asymmetric unit including homodimeric hFc1
residues 241–262, 272–296, 302–321 and 334–443 for chain
A and 237–444 for chain B, two RNA aptamer molecules
(G1-C11 and G16-C23 and G1-A24), two carbohydrate
chains (1–8, 3–7), two Ca
2+ ions, and 254 water molecules,
of which we observe well-deﬁned electron density. The
monomeric hFc1 is composed of two globular domains
(referred to as CH2 and CH3 domains) (Figure 1).
The superimposition of two hFc1 molecules in the
asymmetric unit reveals a minor difference in their con-
formation (rmsd of 1.2A ˚ over 170 aligned Ca atoms). The
difference is very likely caused by crystal packing, because
residues 268 and 298–300 of chain B make van der Waals
contacts with residues 289–292 of a symmetrically related
chain A, while the corresponding regions of chain A does
not (Figure 1c). Ca
2+ ions, which were contained in the
crystallization solution, are observed in the structure of
the aptamers (discussed in detail later). The bound carbo-
hydrate chains are structurally identical to those observed
in the uncomplexed structure of dimeric hFc1 (PDB entry:
1FC1). The model, which has been reﬁned to an Rfree of
27.7%, displays good geometrical parameters (Table 1).
Figure 1. Structure of the aptamer and the aptamer–hFc1 complex. (a) M-fold predicted secondary structure of anti-hFc1 aptamer. Nucleotide
symbols: N (black), RNA; and fN (blue), 20-ﬂuoro modiﬁcation. Note that it differs from the RNA structure in the aptamer–hFc1 complex in
Figure 2. (b) 2Fo–Fc electron density contoured at 1s, corresponding to RNA aptamer. (c) Stereo view of the structure of the aptamer–hFc1
complex. The aptamers and hFc1 are shown in orange and green, respectively. The loop connecting CH2 and CH3 domains are shown in yellow.
Ca
2+ ions bound to the aptamers are indicated by green spheres. The side chains of Lys340 and Gln342, and carbohydrates are shown as stick
models. The areas in contact with the symmetry-related molecules in the crystal lattice are shown in red. (d) Structural comparison of the residues at
the aptamer–hFc1 interface. All the residues of hFc1 responsible for binding to the aptamer are shown as green stick models. The residues of
uncomplexed form of hFc1 (PDB entry: 1FC1), which are superimposed onto the corresponding residues of aptamer-bound hFc1, are shown as
yellow stick model. The black arrow indicates the induced ﬁt of Lys340.
7824 Nucleic Acids Research, 2010,Vol.38, No. 21The overall structure of the aptamer–hFc1 complex is rep-
resented in Figure 1c.
The structure of the aptamer-bound hFc1 can be
superimposed on the uncomplexed form of the structure
of hFc1 (20) (PDB entry: 1FC1) with rmsd of 1.1A ˚ over
357 aligned Ca atoms. This suggests that aptamer binding
caused no signiﬁcant structural changes to the backbone
of hFc1. This deviation value is also comparable to the
rmsd value between two hFc1 molecules within the
aptamer complex. Except for Lys340, the side chains at
the aptamer–hFc1 interface adopt similar conformations
that are observed in the uncomplexed form of hFc1
(Figure 1d) (rmsd of 1.0A ˚ over 82 nonhydrogen atoms
of residues 339–344, 373, 374, 398, 402 and 404). Upon
aptamer binding, the side chain of Lys340 swings  4A ˚
to interact with the phosphate backbone of RNA
(Figure 1d).
RNA structure
Figure 2a shows the overall structure of the RNA
aptamer. The atomic coordinates of the apical loop in
one aptamer could not be determined due to low
electron density, while the apical loop in another
aptamer adopts a GAAA tetraloop. Although G1:C23
and G2:C22 are base paired in one of the aptamers, the
two base pairs in the other aptamer are not formed due to
crystal packing. The structures of the binding region
(A3-C11 and G16-U21) to hFc1 for both aptamers are
almost identical (rmsd of 0.43A ˚ over all nonhydrogen
atoms). The global fold of the aptamer adapts a distorted
hairpin structure with a GAAA tetraloop, an internal
loop, and a terminal A-form helix (Figure 2a). The
characteristic structure of the binding region to hFc1
was predominantly formed by the internal loop, as we
describe below.
The aptamer contains six Watson–Crick type base
pairs, two non-canonical base pairs, and one base triple.
One non-canonical base pair is found in the GAAA
tetraloop (G12:A15 base pair), and the other is a
G5:A19 base pair in the internal loop. The latter is
categorized to be Trans-Sugar Edge/Hoogsteen GA
(36,37). In the internal loop, a U6:A18:U9 base triple is
formed (Figure 2b). In the base triple, U9 and A18 form a
cis-Watson–Crick/Watson–Crick base pair, while U6 and
A18 form a Trans-Watson–Crick/Hoogsteen base pair
(38,39). Bases are continuously stacked in G1-U6,
G7-G12 and A13-C23, whereas the ﬂipping bases of U6
and G7 are not stacked. Torsion angles z for U6 and a, b,
g for G7 adopt non-standard values ( 160 ,8 5  ,  155 
and 175 , respectively) for the base ﬂipping between U6
and G7. Our aptamer contains 20-ﬂuoro substitutions on
pyrimidine residues for ribonuclease resistance. It is
known that 20-ﬂuoro substitutions in RNA increase the
propensity of the sugar to adopt a C30-endo conformation
which results in a stabilized A-form helix (40,41).
Consistent with this propensity, the sugars of all nucleo-
tides including the 20-ﬂuoro pyrimidines adopt a C30-endo
conformation. The 20-ﬂuoro of U6 is crucial for binding to
Fc fragment (19). The conformation of the G7 base is
stabilized by the van der Waals interaction between the
H8 of G7 and the 20-ﬂuoro of U6 (Figure 2c), which also
participates in the U6:A19:U9 base triple.
To investigate the structural and functional contribu-
tion of each nucleotide, mutagenesis experiments of
RNA were further conducted in addition to those
described previously (19) (Figure 2d). When the UAU
base triple was destroyed by mutation, such as
fU6-to-fC, a18-to-t, or fU9:a18-to-fC:G, the aptamer
completely lost its afﬁnity. Similarly, destruction of the
interaction between fU6 and G7 by mutation, such as
fU6-to-U/mU/u and G7-to-A/fU, also caused a loss of
afﬁnity. These data suggest the functional importance of
the interaction between H8 of G7 and 20-ﬂuoro of U6 and
UAU base triple, as observed in the crystal structure. In
addition, the mutation of G5-to-A or fC lost the afﬁnity,
which also suggests the importance of maintaining the
G5:A19 non-canonical base pair.
Role of the divalent cations
In a difference electron density map calculated using a
model lacking metals, a strong peak (at a contour level
of 5s above the mean value of the electron density) was
found in the RNA major groove. These densities cannot
be accounted for by water molecules but rather as heavier
metals. On the basis of an average metal-to-atoms
distance, geometry of the coordination sphere, an atomic
temperature factor and an atomic occupancy (Table 2),
the metal ions were identiﬁed as Ca
2+, which were
present in the crystallization solution. The hydrated
Ca
2+ in the RNA major groove coordinates with no
protein ligands (Figure 3a), but rather binds to
non-bridging oxygen atoms of the G7 phosphates in the
Table 1. Data collection and reﬁnement statistics
Data Collection
Space group P21212
Cell dimensions (A ˚ ,  ) a=83.7, b=107.2, c=79.0




Completeness (%) 98.3 (89.1)
b
No. of measured reﬂections 195721





Resolution (A ˚ ) 30.5–2.15
No. of reﬂections 36041










Bond lengths (A ˚ ) 0.006
Bond angles ( ) 1.2
aRmerge=|I(k)-I|/I(k), where I(k) is value of the kth measurement of
the intensity of a reﬂection, I is the mean value of the intensity of that
reﬂection and the summation is the over all measurements.
bValues in parentheses are for the highest resolution shell (2.23–2.15A ˚ ).
Nucleic Acids Research, 2010,Vol.38, No. 21 7825RNA. Therefore, Ca
2+ also may help to maintain the dis-
tinct conformation of G7, which is one of the
hFc1-interacting residues (described later). This site
might also be occupied by Mg
2+, since the aptamer
could bind to hFc1 in the presence of Ca
2+ or Mg
2+.
To investigate the importance of Ca
2+ for the afﬁnity,
surface plasmon resonance (SPR) experiments were con-
ducted with different running buffer conditions. Under a
condition without divalent cations, such as PBS or saline,
the aptamer could not bind to human IgG (hIgG).
Addition of EDTA, a chelating agent, caused loss of
afﬁnity and the afﬁnity was regained with addition of
Ca
2+ (Figure 3b). These biochemical assays indicate the
importance of divalent cations for the aptamer activity.
The reversible binding suggests reversible folding of the
aptamer, achieved by the presence of the divalent cation.
The SPR analysis demonstrates that this conformational
change is reversible and rapid, and therefore can also be
envisioned as a sensor for divalent cations. In cells, such
cation-speciﬁc sensors are also known as naturally
occurring riboswitches (42–44).
Interaction between the aptamer and hFc1
The interaction between the aptamer and hFc1 is
summarized in Figure 4a. The interaction involves
hydrogen bonding and van der Waals forces, and only
one ion-pair was observed between the backbone phos-
phate of G7 and the side chain of Lys340. Analysis of
the surface electrostatic potential in hFc1 demonstrates
that the aptamer-bound area consists of a less-positively
charged surface (Figure 4b). This feature is signiﬁcantly
different from aptamer complexes with NF-kB (15) and
bacteriophage MS2 capsid (16), which also naturally bind
nucleic acids (Supplementary Figure S1), or to the
aptamer complex with thrombin, which does not naturally
bind nucleic acid (17) (Figure 4c).
The interaction between hFc1 and aptamer covers
580A ˚ 2 of surface area per Fc fragment, and this area is
relatively small to the area covered by the other RNA
aptamer interactions (ca. 1000A ˚ 2) (13–15). The average
Figure 2. Overall structure of the aptamer within the aptamer–hFc1 complex. (a) Tertiary (left) and secondary (right) structures of the bound
aptamer. Ca
2+ is shown as green sphere. The nucleotide sequences are color coded as follows: adenine, red; guanine, cyan; 20-ﬂuoro uridine, green;
and 20-ﬂuoro cytidine, yellow. (b) U6:A18:U9 base triple. The interactions are indicated with thin dashed lines and the distances (A ˚ ) are given in
black. RNA atoms are colored, red, blue, light blue and orange for oxygen, nitrogen, ﬂuorine and phosphorus, respectively. The color coding of the
carbon is the same as in Figure 2a.( c) Interaction between the H8 of G7 and the 20-ﬂuoro of U6. The H8 atom is shown at the calculated ideal
positions. (d) Functional annotation of base substitutions and ribose 20 modiﬁcations in the anti-hFc1 aptamer. Base substitutions described pre-
viously (19) and those newly manipulated in this study are indicated in the M-fold structure of Apt8-2 (19), a functional derivative of the aptamer
used for crystallization. Each oligonucleotide with the indicated substitutions were chemically synthesized and examined for afﬁnity to hIgG1 by
SPR. Nucleotide symbols: N (black), RNA; n (green), DNA; fN (blue), 20-ﬂuoro modiﬁcation; and mN (orange), 20 O-methyl modiﬁcation. All
substitutions shown here completely abrogated binding activity.











1 65.17 0.86 1.52 1.41 2.50
2 54.05 1.01 1.77 1.68 2.68
aThe peak corresponds to the electron density peak. Peaks 1 and 2 are
located in the major groove of the aptamer, while peaks 3 and 4 are
observed at the aptamer–hFc1 interface.
bThe average B-factors were calculated and averaged from the atoms
within a 5A ˚ radius of the peak (left column).
cThe atomic occupancy reﬁnements were carried out by CNS (31).
Before the reﬁnement, the cations (Ca
2+,N a
+,M g
2+, and water) were
put at the peak of the electron density; then, the temperature factors of
the atoms were set to the average B-factor (centre columns). Peaks 1
and 2 are likely to be equivalent to Ca
2+ because the calculated values
of the atomic occupancy are close to 1.
7826 Nucleic Acids Research, 2010,Vol.38, No. 21contact area of all amino acids that interact with the
aptamer is 30A ˚ 2. The contact area of the aptamer’s G7
to hFc1 is the largest and covers 110A ˚ 2, whereas the
average contact area of all interacting nucleotides is
35A ˚ 2. As shown in Figure 4d, the ﬂipped base of G7 is
stabilized by the following interactions: the stacking inter-
action between the G7 base and the side chain of Tyr373;
the hydrogen bonds between N2 of the G7 base and the
Figure 4. Interactions of the aptamer with target proteins. (a) Interactions between hFc1 and the aptamer are color-typed: red, ion pair; green,
hydrogen bond; brown, van der Waals contact; blue, stacking interaction. (b) Overall structure of aptamer–hFc1 complex with the electrostatic
surface potential of hFc1. The RNA aptamer is shown as a yellow ball-and-stick model. (c) Structure of aptamer–thrombin complex with the
electrostatic surface potential of thrombin (17) with the RNA aptamer. (d) The detailed interaction of the base of G7 with the RNA aptamer and
protein portions. (e) The continuous stacking interaction between hFc1 and RNA aptamer. (f) The detailed interaction of the side chain of Gln342.
Images of the electrostatic surface potential were produced by ICM Pro (Molsoft Inc.) using default setting: the potential scale used was 5.
Figure 3. (a) Coordination spheres of Ca
2+. The interactions are indicated with thin dashed lines and selected nucleotides are labeled. Ca
2+ is bound in a
distorted octahedral coordination environment with the phosphate backbone and ﬁve water molecules (left). In the enlarged view (right), only one
water molecule involved in the aptamer binding is shown for clarity. The Ca
2+ and the water molecule are shown with green and red spheres,
respectively. (b) A SPR sensorgram of IgG-aptamer interactions. Folding and unfolding the aptamer was repeated 10 times. Arrows: 1, injection of
hIgG dissolved in binding buffer; 2, injection of unfolding buffer. Experimental procedures and conditions are described in Supplementary Notes online.
Nucleic Acids Research, 2010,Vol.38, No. 21 7827carbonyl oxygen of Gly402, as well as the O6 of the G7
base and the side chain of Arg344; and van der Waals
contacts between the G7 base and 20-ﬂuoro of U6
ribose. Bases G7-G12 continuously stack on Tyr373 and
Pro374 of hFc1 (Figure 4e), revealing structural adapta-
tions that create a characteristic interaction. In addition,
the 20-ﬂuoro groups of the C8 and the C20 potentially
stabilize the aptamer–hFc1 interaction. The 20-ﬂuoro
group of the C8 makes van der Waals contacts with the
side chain of Leu398 and the 20-ﬂuoro group of the C20
contacts the side chains of Gln342 and Arg344. The
previous mutagenesis studies have indicated that
20-ﬂuoro groups of C8 and C20 could be replaced by
hydroxyl groups (19).
DISCUSSION
The aptamer binds to four subtypes of human IgGs, IgG1
through IgG4, but not to IgGs from other species,
including mouse, rat, rabbit, bovine, feline and canine
(19). It is likely that Gln342 and Phe404, conserved in
human IgG1-4, play key roles for the speciﬁcity as they
interact directly with the aptamer. The largest contact area
(75A ˚ 2) in hFc1 is occupied by Gln342, which is located in
the loop connecting the CH2 and CH3 domains. The side
chain of Gln342 interacts with N2 of the base G4, O2 of
the base C20 and O40 of the ribose in U21 (Figure 4f).
Gln342 is also conserved in rabbit and feline IgG.
Therefore, Gln342 is not the only residue crucial for the
speciﬁcity. The other key residue seems to be Phe404,
which directly interacts with G7 (Figure 4a). At this
position, Phe is substituted by Tyr in the other species,
with the exception of rat IgG, and this substitution
would likely lead to steric hindrance with G7. Since the
presence of both of these residues is common only to
human IgG1-4, we conclude that the two residues are
most important for the speciﬁcity of the aptamer.
RNA generally binds to proteins via an electrostatic
interaction between the negatively charged phosphate
backbones and the positively charged surface of
proteins. However, the stacking interaction between G7
and Tyr373 was one of the major interactions in the
aptamer–hFc1 complex. As shown in Figure 4b, the
aptamer obviously interacts through the weaker forces
supported by van der Waals contacts and hydrogen
bonds. This study strongly suggests that SELEX technol-
ogy can select for not only molecules that interact through
predominantly electrostatic forces (13–15), but also high
speciﬁcity molecules that interact through weaker forces
such as van der Waals contacts and hydrogen bonds. The
nature of the latter resembles that of protein-protein inter-
actions, rather than that of nucleic acids-protein
interactions.
The crystal structure revealed that oxygen atoms of the
phosphate of G7 is bound to a divalent ion, which is
located in the major groove of the aptamer but not
located in the interface between the aptamer and hFc1.
Thus, it is suggested that the divalent ion is important
for folding the active structure of the aptamer, and
could be quickly removed by a chelating agent. Indeed,
the SPR analysis demonstrated that the active structure of
the aptamer is destabilized with EDTA solution, but
quickly refolds by adding the divalent cations again. It is
noteworthy that hFc1 undergoes no conformational
change upon binding to the aptamer. This, in turn, em-
phasizes conformational plasticity of aptamer RNA.
Consequently, this aptamer could be a novel ligand for
afﬁnity puriﬁcation of therapeutic antibodies and can sub-
stitute for protein A to avoid possible loss-of-quality
during the acid elution process.
In summary, the most intriguing ﬁndings in the current
study are related to the multiple weaker interactions,
rather than electrostatic forces, that contribute to the
highly selective and strong binding to the target protein,
and to the fact that the hFc1 conformation is the least
affected by aptamer binding. These ﬁndings demonstrate
excellent conformational plasticity of RNA molecules,
and therefore suggest that RNA aptamers may be applic-
able to a wider range of targets than previously expected.
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